Product Information
ACETAZOLAMIDE 250 MG TABLET is a generic product labeled by Viona Pharmaceuticals Inc., priced at $0.1340 per EA under NDC 72578015001. Its NADAC has been published 143 times since Jan 10, 2024.
FDA first approved this application on Apr 4, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
250 mg/1
Manufacturer
Viona Pharmaceuticals Inc.NDC
72578015001
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ACETAZOLAMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA211069FDA Approved
4/4/2023
TE Code
AB
On Market Since
7/15/2023
Pharmacological Classes
Price Statistics
The NADAC for ACETAZOLAMIDE 250 MG TABLET has been published 143 times since Jan 10, 2024, and over the history we have for it it has declined 29.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1340 per EA |
|---|---|
| All-time high | $0.2147 (Mar 13, 2024) |
| All-time low | $0.1231 (Dec 17, 2025) |
| 52-week high | $0.1489 |
| 52-week low | $0.1231 |
| Median price | $0.1420 |
| Average price | $0.1509 |
| Largest weekly change | +43.4% (Jun 19, 2024) |
| Weeks tracked | 143 |
| Tracking since | Jan 10, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the acetaZOLAMIDE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Viona Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
acetaZOLAMIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Carbonic Anhydrase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ACETAZOLAMIDE 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ACETAZOLAMIDE 250 MG TABLET, manufactured by Viona Pharmaceuticals Inc., is $0.1340 per EA (NDC 72578015001), effective Sep 30, 2026.
How has the price of ACETAZOLAMIDE 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for ACETAZOLAMIDE 250 MG TABLET has declined 29.0%. It has been tracked across 143 weekly CMS publications since Jan 10, 2024.
What are the highest and lowest recorded NADAC prices for ACETAZOLAMIDE 250 MG TABLET?
Since Jan 10, 2024, the NADAC for ACETAZOLAMIDE 250 MG TABLET has ranged from a low of $0.1231 (Dec 17, 2025) to a high of $0.2147 (Mar 13, 2024), with a median of $0.1420 per EA.
Are there cheaper alternatives to ACETAZOLAMIDE 250 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of ACETAZOLAMIDE 250 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ACETAZOLAMIDE 250 MG TABLET?
ACETAZOLAMIDE 250 MG TABLET (NDC 72578015001) is labeled by Viona Pharmaceuticals Inc., and CMS classifies it as a generic product.